1 / 17

Placebo and Opioid Analgesia - Imaging a Shared Neuronal Network

Placebo and Opioid Analgesia - Imaging a Shared Neuronal Network. Predrag Petrovic, Karl Magnus Petersson,

adeola
Download Presentation

Placebo and Opioid Analgesia - Imaging a Shared Neuronal Network

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Placebo and Opioid Analgesia-Imaging a Shared Neuronal Network Predrag Petrovic, Karl Magnus Petersson, Eija Kalso,Martin IngvarCognitive Neurophysiology Research Group, Department of Clinical Neuroscience, Karolinska Institute, Stockholm 171 76, Sweden., Pain Clinic, Department of Anaesthesia and Intensive Care Medicine, Helsinki University Hospital, Finland. SCIENCE VOL295 1737~1740 強伍翎

  2. ＊Background ◎ Brain (1) Oribitofrontal cortex (2) Brainstem(PAG, pon)(3) Thalamus(4) CC (ACC, rACC, caudal ACC)

  3. ＊Background (continued) ◎ Pain ◎ Endogenous opioid system (receptor and ligand), analgesia and antagonist ◎ Importance of ACC (rACC) in opioid effect

  4. ＊Background (continued) ◎ Placebo analgesia and effect ◎ PET (Positron emission tomography )◎ rCBF (regional cerebral blood flow)

  5. ＊Experiment ◎ Purpose To compare analgesic effect between placebo and opioid treatment. ◎ Material Placebo— Saline Opioid— Remifentanil (0.5μg/Kg) Nine people

  6. ◎ Method Standard pain-stimulus paradigm (1) POP (heat pain with opioid treatment) (2) WOP (warm nonpain〃 ) (3) PPL(heat pain with placebo treatment) (4) WPL (warm nonpain〃) (5) P (heat pain only) (6) W (warm nonpain〃) Heat pain— 48°C, 70s Nonpainful wram stimulation— 38°C, 70s

  7. ◎ Method (continued) Double Blind(for OP and PL) Inform subject for no analgesia Each person 2 blocks Study (1) Behavior Response — VAS (2) rCBF — PET(450MBq[15O]H2O)

  8. ＊Result ◎Behavior Result (1) P POP(2) P PPL(3) PPL POP Placebo responder — Low (<10%) — High (>10%)

  9. ◎ PET Result I.(1)Main effect of Pain [(POP+PPL+P)-(WOP+WPL+W)] w) + + P=0.005

  10. ◎ PET Result (continued) (2) Main effect of Opioid[(POP+WOP)-(P+W)] P=0.001 P=0.005

  11. ◎ PET Result (continued) (3) Effect of Placebo (during pain) (PPL-P) P=0.001 P=0.005

  12. ◎ PET Result (continued) Placebo mask with opioid network P=0.005

  13. ◎ PET Result (continued) II. Compare high and low placebo responder in PPL-P and POP-P POP-P P= 0.005 High placebo responder Low placebo responder Z=4.77 Z=3.24

  14. ◎ PET Result (continued) n.s.= subsignificant changes III. Regression analysis Covariation between rACC and the brainstem Blue — rACC P=0.005

  15. ＊Conclusion ◎ Both opioid and placebo are associated with increased activity in rACC◎ A covariation between activity in rACC and brainstem during both opioid and placebo analgesia, but not pain-only A related neural mechanism in placebo and opioid analgesia.

  16. ＊Suggestion ◎ Orbitofrontal cortex has dense connection with ACC and brainstem , therefore suggest these region belong to a network using cognitive cue to activate the endogenous opioid system.

  17. ＊Doubt and reflection ◎ II

More Related